After a median follow-up of 46.2 months (95% CI: 41.0–56.6 months), only three events in three different patients were detected in the form of bone metastasis (two in TNBC, one in HR+/HER2− BC) and only in one of these patients additional positive nodes after ALND had been detected. The gene discussed is ERBB2; the disease is breast cancer.